Urology
Volume 75, Issue 6 , Pages 1278-1282 , June 2010

Utility of Urine Cytology in the Workup of Asymptomatic Microscopic Hematuria in Low-risk Patients

  • Andrew H. Feifer

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada
    • ,
  • Jordan Steinberg

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada
    • ,
  • Simon Tanguay

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada
    • ,
  • Armen G. Aprikian

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada
    • ,
  • Fadi Brimo

      Affiliations

    • Department of Pathology, McGill University, Montreal, Quebec, Canada
    • ,
  • Wassim Kassouf

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Wassim Kassouf, M.D., F.R.C.S.(C), Division of Urology, McGill University Health Centre, 1650 Cedar Ave, Rm. L8–315, Montreal, QC H3G 1A4, Canada

Received 14 July 2009 ,Accepted 17 September 2009.

References 

  1. Presti JC, Weyrauch HM. Papanicolaou examination of urine in diagnosis of urinary cancer (I. As a test in mass screening). Trans West Sect Am Urol Assoc. 1954;21:150–154
  2. Konety BR, Metro MJ, Melham MF, et al. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract. Urol Int. 1999;62:26–30
  3. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–2119
  4. Renshaw AA. Subclassifying atypical urinary cytology specimens. Cancer. 2000;90:222–229
  5. Goldstein ML, Whitman T, Renshaw AA. Significance of cell groups in voided urine. Acta Cytol. 1998;42:290–294
  6. Lotan Y, Capitanio U, Shariat SF, et al. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int. 2009;103:1368–1374
  7. Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293:810–816
  8. Bastacky S, Ibrahim S, Wilczynski SP, et al. The accuracy of urinary cytology in daily practice. Cancer. 1999;87:118–128
  9. Brown FM. Urine cytology (It is still the gold standard for screening?). Urol Clin North Am. 2000;27:25–37
  10. Grossfeld GD, Carroll PR. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am. 1998;25:661–676
  11. Wollin T, Laroche B, Psooy K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. Can Urol Assoc J. 2009;3:77–80
  12. Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001;57:604–610
  13. Sutton JM. Evaluation of hematuria in adults. JAMA. 1990;263:2475–2480
  14. Raab SS, Slagel DD, Jensen CS, et al. Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy. Mod Pathol. 1996;9:225–232
  15. Fracchia JA. My approach to the patient with asymptomatic microhematuria. Contemp Urol. 1997;9:74–78
  16. Raitanen MP, Aine R, Rintala E. Differences between local and review urinary cytology diagnosis of bladder cancer: an inter-observer multicenter analysis. Eur Urol. 2002;41:284–289
  17. Wiener HG, Vooijs GP, van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol. 1993;37:163–169
  18. Sultana SR, Goodman CM, Byrne DJ, et al. Microscopic hematuria: urological investigation using a standard protocol. Br J Urol. 1996;78:691–696
  19. Alishahi S, Byrne D, Goodman CM, et al. Hematuria investigation based on a standard protocol: emphasis on the diagnosis of urological malignancy. J R Coll Surg Edinb. 2002;47:422–427
  20. Khan MA, Shaw G, Paris AM. Is microscopic hematuria a urological emergency?. BJU Int. 2002;90:355–357
  21. Deshpande V, McKee GT. Analysis of atypical urine cytology in a tertiary care center. Cancer. 2005;105:468–475
  22. Voss JS, Kipp BR, Krueger AK, et al. Changes in specimen preparation method may impact urine cytologic evaluation. Am J Clin Pathol. 2008;130:428–433
  23. Karakiewicz P, Benayoun S, Zippe C, et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int. 2006;97:997–1001
  24. Kapur U, Venkataraman G, Wojcik EM. Diagnostic significance of “atypia” in instrumented versus voided urine specimens. Cancer. 2008;114:270–274
  25. Mohr DN, Offord KP, Owen RA, et al. Asymptomatic micro-hematuria and urologic disease: a population based study. JAMA. 1986;256:224–229
  26. Britton JP, Dowell AC, Whelan P. Dipstick hematuria and bladder cancer in men over 60: results of a community study. BMJ. 1989;299:1010–1012
  27. Messing EM, Young TB, Hunt VB, et al. The significance of asymptomatic micro-hematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol. 1987;137:919–922
  28. Hofland CA, Mariani AJ. Is cytology required for a hematuria evaluation?. J Urol. 2004;171:324–326
  29. Rodgers M, Nixon J, Hempel S, et al. Diagnostic tests and algorithms used in the investigation of hematuria: systematic reviews and economic evaluation. Health Technol Assess. 2006;10:iii–ivxi-259
  30. Mishriki SF, Nabi G, Cohen NP. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up. Urology. 2008;71:13–16

 This work is supported by The Fonds de la Recherch en Santé du Quebec.

PII: S0090-4295(09)02948-3

doi: 10.1016/j.urology.2009.09.091

Urology
Volume 75, Issue 6 , Pages 1278-1282 , June 2010

Article Tools